Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion

Author(s):
Garderet, L.; Ziagkos, D.; Biezen, A. van; Lacobelli, S.; Finke, J.; Maertens, J.; Volin, L.; Ljungman, P.; Chevallier, P.; Passweg, J.; Schaap, N.; Beelen, D.; Nagler, A.; Blaise, D.; Poire, X.; Yakoub-Agha, I.; Lenhoff, S.; Craddock, C.; Schots, R.; Rambaldi, A.; Sanz, J.; Jindra, P.; Mufti, G.J.; Robin, M.; Kroeger, N.
Published
2018
Publication type
Article / Letter to editor
MDSdel (5q)Allogeneic stem cell transplantation
Date issued
2018-03-31
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2018), Vol. 24, no. 3, p. 507-513
hdl
1887/79364
doi
10.1016/j.bbmt.2017.11.017